NasdaqGS - Delayed Quote USD

Tenaya Therapeutics, Inc. (TNYA)

0.4600
+0.0156
+(3.51%)
At close: May 30 at 4:00:01 PM EDT
0.4549
-0.01
(-1.11%)
After hours: May 30 at 7:57:12 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
109,724
115,948
131,193
125,621
72,806
Operating Income
-109,724
-115,948
-131,193
-125,621
-72,806
Net Non Operating Interest Income Expense
3,920
4,737
7,056
1,954
108
Other Income Expense
39
82
53
2
-23
Pretax Income
-105,765
-111,129
-124,084
-123,665
-72,721
Tax Provision
0
0
0
0
0
Net Income Common Stockholders
-105,765
-111,129
-124,084
-123,665
-72,721
Diluted NI Available to Com Stockholders
-105,765
-111,129
-124,084
-123,665
-72,721
Basic EPS
-1.15
--
-1.68
-2.76
-4.10
Diluted EPS
-1.15
--
-1.68
-2.76
-4.10
Basic Average Shares
92,044.2060
--
73,786.1260
44,823.5970
17,734.1660
Diluted Average Shares
92,044.2060
--
73,786.1260
44,823.5970
17,734.1660
Total Operating Income as Reported
-109,724
-115,948
-131,193
-125,621
-72,806
Total Expenses
109,724
115,948
131,193
125,621
72,806
Net Income from Continuing & Discontinued Operation
-105,765
-111,129
-124,084
-123,665
-72,721
Normalized Income
-105,765
-111,129
-124,084
-123,665
-72,721
Interest Income
3,920
4,737
7,056
1,954
108
Net Interest Income
3,920
4,737
7,056
1,954
108
EBIT
-109,724
-115,948
-131,193
-125,621
-72,806
EBITDA
-100,750
-107,480
-122,506
-119,154
-69,845
Reconciled Depreciation
8,974
8,468
8,687
6,467
2,961
Net Income from Continuing Operation Net Minority Interest
-105,765
-111,129
-124,084
-123,665
-72,721
Normalized EBITDA
-100,750
-107,480
-122,506
-119,154
-69,845
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 7/30/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ALXO ALX Oncology Holdings Inc.
0.4855
+3.92%
 
VOR Vor Biopharma Inc.
0.1999
+2.46%
 
PASG Passage Bio, Inc.
0.4363
-3.41%
 
CNTX Context Therapeutics Inc.
0.5771
-6.50%
 
MRSN Mersana Therapeutics, Inc.
0.3437
-1.52%
 
CHRS Coherus BioSciences, Inc.
0.7790
-2.87%
 
IMUX Immunic, Inc.
0.6599
-2.97%
 
RANI Rani Therapeutics Holdings, Inc.
0.5592
-3.45%
 
TSHA Taysha Gene Therapies, Inc.
2.7100
-1.45%
 
KYTX Kyverna Therapeutics, Inc.
2.5500
-3.04%